[HTML][HTML] Decline in menarcheal age among Saudi girls
IA Al Alwan, AA Ibrahim, MA Badri… - Saudi medical …, 2015 - ncbi.nlm.nih.gov
Objectives: To estimate age at menarche and to assess trends in menarcheal age among
Saudi women. Methods: A prospective longitudinal study was conducted among healthy …
Saudi women. Methods: A prospective longitudinal study was conducted among healthy …
Effect of highly active antiretroviral therapy on incidence of tuberculosis in South Africa: a cohort study
M Badri, D Wilson, R Wood - The Lancet, 2002 - thelancet.com
Background Studies of the effect of highly active antiretroviral therapy (HAART) on the risk of
HIV-1-associated tuberculosis have had variable results. We set out to determine the effect …
HIV-1-associated tuberculosis have had variable results. We set out to determine the effect …
[HTML][HTML] Early treatment outcomes and HIV status of patients with extensively drug-resistant tuberculosis in South Africa: a retrospective cohort study
Background Data from Kwazulu Natal, South Africa, suggest that almost all patients with
extensively drug-resistant (XDR) tuberculosis are HIV-positive, with a fatal outcome. Since, there …
extensively drug-resistant (XDR) tuberculosis are HIV-positive, with a fatal outcome. Since, there …
Long-term outcomes of patients with extensively drug-resistant tuberculosis in South Africa: a cohort study
…, B Mastrapa, X Padanilam, A Pooran, M Badri… - The Lancet, 2014 - thelancet.com
Background Long-term treatment-related outcomes in patients with extensively drug-resistant
(XDR) tuberculosis are unknown. We followed up a cohort of patients to address …
(XDR) tuberculosis are unknown. We followed up a cohort of patients to address …
Nursing homes as a reservoir of extended-spectrum β-lactamase (ESBL)-producing ciprofloxacin-resistant Escherichia coli
…, B Smyth, P Donaghy, M Badri… - Journal of …, 2009 - academic.oup.com
Background To assess the prevalence and risk factors for faecal carriage of fluoroquinolone-resistant,
extended-spectrum β-lactamase (ESBL)-producing, Escherichia coli (MDR E. coli) …
extended-spectrum β-lactamase (ESBL)-producing, Escherichia coli (MDR E. coli) …
Within-subject variability and boosting of T-cell interferon-γ responses after tuberculin skin testing
…, R Meldau, J Kieck, J Juritz, M Badri… - American journal of …, 2009 - atsjournals.org
Rationale: The optimal strategy for the diagnosis of latent tuberculosis infection is controversial.
Adoption of a two-step strategy (tuberculin skin test [TST] followed by an IFN-γ release …
Adoption of a two-step strategy (tuberculin skin test [TST] followed by an IFN-γ release …
[HTML][HTML] Clinical utility of a commercial LAM-ELISA assay for TB diagnosis in HIV-infected patients using urine and sputum samples
Background The accurate diagnosis of TB in HIV-infected patients, particularly with advanced
immunosuppression, is difficult. Recent studies indicate that a lipoarabinomannan (LAM) …
immunosuppression, is difficult. Recent studies indicate that a lipoarabinomannan (LAM) …
Short-term risk of AIDS or death in people infected with HIV-1 before antiretroviral therapy in South Africa: a longitudinal study
Background In sub-Saharan Africa, data for short-term risk of AIDS or death, which might
inform decisions about when to start antiretroviral therapy (ART), are scarce. Our aim was to …
inform decisions about when to start antiretroviral therapy (ART), are scarce. Our aim was to …
[HTML][HTML] Cost-effectiveness of highly active antiretroviral therapy in South Africa
M Badri, G Maartens, S Mandalia, LG Bekker… - PLoS …, 2006 - journals.plos.org
Background Little information exists on the impact of highly active antiretroviral therapy (HAART)
on health-care provision in South Africa despite increasing scale-up of access to …
on health-care provision in South Africa despite increasing scale-up of access to …
[HTML][HTML] A single-blinded trial of methotrexate versus azathioprine as steroid-sparing agents in generalized myasthenia gravis
…, A Rawoot, K Bateman, R Renison, M Badri - BMC neurology, 2011 - Springer
Background Long-term immunosuppression is often required in myasthenia gravis (MG).
There are no published trials using methotrexate (MTX) in MG. The steroid-sparing efficacy of …
There are no published trials using methotrexate (MTX) in MG. The steroid-sparing efficacy of …